Forward Citations = 4

Loading Chart...

4 inventors (with patents filed for the assignee):

Po-I Wu (5 out of 6 patents)

Yu-Ling Tsai (3 out of 3 patents)

Chih-Jung Chang (3 out of 21 patents)

4. Tzu-Lung Lin (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 11253541 - Method of inhibiting inflammatory response using lipopolysaccharide of (2022-02-22),

2. 11235009 - Method of ameliorating chronic kidney disease using (2022-02-01),

3. 11166988 - Method of ameliorating chronic obstructive pulmonary disease using (2021-11-09),

4. 11147843 - Method of preventing or treating obesity using a novel strain of (2021-10-19),

5. 11116803 - Method of treating lung cancer using (2021-09-14),

Company Overview

Multistars Biotechnology Company Limited is a leading biotech company specializing in the discovery and development of innovative biopharmaceuticals. With a focus on cutting-edge technologies and scientific research, we strive to improve patient outcomes and advance global healthcare. Our team of experienced scientists and researchers are dedicated to pushing the boundaries of biotechnology and delivering groundbreaking solutions to address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#204 in Taoyuan

#2,367 in Taiwan

Taoyuan, Taiwan

Multistars Biotechnology Company Limited

Forward Citations = 4

4 inventors:

Po-I Wu (5 out of 6 patents)

Yu-Ling Tsai (3 out of 3 patents)

Chih-Jung Chang (3 out of 21 patents)

4. Tzu-Lung Lin (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Multistars Biotechnology Company Limited. Retrieved from https://idiyas.com/company/multistars-biotechnology-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]